TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PBH

Prestige Brand Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

45.30$ +1.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Prestige Brand Holdings Inc (PBH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at 258 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow PBH
Line item 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
2.0 3.9 13 6.1 51 54 72 45 67 59 87 67 138 112 156 174 148 210 189 217 236 260 230 249 252 258
– 4.0 5.3 5.4 13 13 14 14 11 13 10 11 13 13 18 24 26 33 32 29 30 32 33 31 30 31
– – – 1.4 – 0.4 0.7 1.1 2.4 2.1 3.6 3.1 3.8 5.1 6.9 10.0 8.1 8.9 7.4 7.6 8.5 9.0 12 14 11 11
– – – 0.1 – 1.8 – – – – – 17 30 24 36 46 -52 -154 196 24 34 22 323 – – –
– – – -7.8 -9.2 -11 12 -14 7.9 -3.8 31 -5.4 13 -12 13 -22 -13 -16 -8.3 8.8 -5.6 -11 -54 -40 -42 -18
0.0 0.1 0.4 0.6 0.4 23 0.5 0.5 0.5 0.7 0.7 0.6 10 2.8 6.1 3.6 3.0 13 10 15 22 9.6 7.8 9.6 8.2 11
– -4.4 -2.2 -167 -426 -54 -31 -0.5 -4.7 7.3 -276 -662 11 -58 -805 -223 -695 -12 55 -17 -22 -257 -12 -20 -17 -137
– – – – – – – – – – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.3 2.9 4.1 – – – –
– – – – 0.0 – 0.0 – 0.0 – – 0.9 6.0 -0.7 -2.1 -2.2 -1.4 -1.1 -50 -57 -12 -2.9 -50 -25 -52 -156
– – – – – – – – – – – 600 -158 -48 640 350 1,427 -210 -200 -75 -268 -9.1 -135 -228 -140 0.5
36 5.5 -15 163 377 3.2 -35 -52 -33 -61 161 600 -152 -41 643 54 562 -209 -249 -131 -279 -7.6 -186 -241 -182 -156
38 5.5 -15 -0.1 1.9 2.9 5.6 -7.7 29 5.9 -28 5.7 -3.3 13 -7.0 5.9 15 -9.3 -5.0 67 -62 -5.1 31 -12 51 -34
2.0 3.8 12 5.5 51 31 71 44 66 59 86 67 127 109 150 171 145 198 179 203 213 250 222 239 243 246

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?